Current approaches to develop vaccines against tuberculosis (TB), one of the top 10 causes of death globally, are based primarily on the induction of conventional, major-histocompatibility complex (MHC)-restricted, Th1 cytokine-producing T cells to protein antigens. The gene discussed is HLA-C; the disease is tuberculosis.